NRSN
NeuroSense Therapeutics Ltd
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.86
+0.01 ▲ +1.11%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$0.86
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -0.58 | Insider Own | 21.54% | Shs Outstand | 0.03B | Perf Week | -0.76% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | 8.8% | Insider Trans | - | Shs Float | 0.02B | Perf Month | -14.91% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | -0.11 | Inst Own | 1.17% | Short Float | 2.16% | Perf Quarter | -1.78% |
| Income | -0.01B | P/S | - | EPS this Y | 35.82% | Inst Trans | 6.82% | Short Ratio | 2.25 | Perf Half Y | -25.27% |
| Sales | 0.00B | P/B | 7.73 | EPS next 5Y | 28.59% | ROA | -263.45% | Short Interest | 0.50M | Perf YTD | 11.76% |
| Book/sh | 0.11 | P/C | 7.48 | EPS past 3/5Y | 35.88% 2.71% | ROE | -2880.11% | 52W High | -66.95% ($2.60) | Perf Year | -23.27% |
| Cash/sh | 0.11 | P/FCF | - | Sales past 3/5Y | - | ROIC | -395.28% | 52W Low | 26.36% ($0.68) | Perf 3Y | -50.61% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 31.09% | Gross Margin | - | Volatility(W/M) | 6.72% 7.74% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.07 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.21 | EPS Q/Q | 59.59% | Profit Margin | - | RSI (14) | 45.9 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.21 | Sales Q/Q | - | SMA20 | -2.73% ($0.88) | Beta | 1.63 | Target Price | $8.38 |
| Payout | - | Debt/Eq | 0.03 | Earnings | 2025/11/26 | SMA50 | -6.73% ($0.92) | Rel Volume | 0.17 | Prev Close | $0.85 |
| Employees | 15 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 8.47% - | SMA200 | -32.05% ($1.27) | Avg Volume(3M) | 0.22M | Price | $0.86 |
| IPO | 2021/12/9 | Option/Short | No/Yes | Trades | 137 | Volume | 37,120 | Change | 1.11% |
뉴스 로딩 중...